Markedly disturbed glutathione redox status in CD45RA+CD4+ lymphocytes in human immunodeficiency virus type 1 infection is associated with selective depletion of this lymphocyte subset

Blood

Volumn 88, Issue 7, 1996, Pages 2626-2633

  Aukrust, Pål ^a   Svardal, Asbjørn M ^b   Müller, Fredrik ^b   Lunden, Bodil ^b   Nordøy, Ingvild ^b   Frøland, Stig S ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE REDUCTASE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTOPENIA; MALE; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0029846523     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.7.2626.bloodjournal8872626     Document Type: Article

References (49)

1. Sies H: Oxidative stress: From basic research to clinical application. Am J Med 91:31S, 1991 (suppl 3C)
2. Meister A: Glutathione metabolism and its selective modification. J Biol Chem 263:17206, 1988
3. Hamilos DL, Wedner HJ: The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation. J Immunol 135:2740, 1985
4. Yamauchi A, Bloom ET: Requirement of thiol compounds as reducing agents for IL-2 mediated induction of LAK activity and proliferation of human NK cells. J Immunol 151:5535, 1993
5. Droge W, Pottmeyer-Greber C, Schmidt H, Nik S: Glutathione augments the activation of cytotoxic T lymphocytes in vivo. Immunobiol 171:151, 1986
6. Buttke TM, Sandstrom PA: Oxidative stress as a mediator of apoptosis. Immunol Today 15:7, 1994
7. Staal FTJ, Ela SW, Roederer M, Anderson MT, Herzenberg LA, Herzenberg LA: Glutathione deficiency and human immunodeficiency virus infection. Lancet 339:909, 1992
8. + lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection. Blood 86:258, 1995
9. Sanders ME, Makgoba MW, Shaw S: Human naive and memory T cells. Immunol Today 9:195, 1988
10. Beverly P: Immunological memory in T cells. Curr Opin Immunol 3:355, 1991
11. Merkenschlager M, Terry L, Edwards R, Beverly PC: Limiting dilution analysis of proliferative responses in human lymphocyte populations defined by monoclonal antibody UCHL1: Implications for differential CD45 expression in T cell memory formation. Eur J Immunol 18:1653, 1988
12. Akbar AN, Terry L, Timms A, Beverly PC, Janossy G: Loss of CD45R and gain of UCHLI reactivity is a feature of primed T cells. J Immunol 140:2171, 1988
13. Roederer M, Dubs JG, Anderson MT, Raju PA, Herzenberg LA, Herzenberg LA: CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest 95:2061, 1995
14. Chou C-C, Gudeman V, O'Rourke S, Isacescu V, Detels R, Williams GJ, Mitsuyasu RT, Giorgi JV: Phenotypically defined memory CD4+ cells are not selectively decreased in chronic HIV disease. J AIDS 7:665, 1994
15. Akbar AN, Salmon M, Savill J, Janossy G: A possible role for bcl-2 in regulating T-cell memory - a "balancing act" between cell death and survival. Immunol Today 14:526, 1993
16. Picker LJ, Singh MK, Zdraveski Z, Treer JR, Waldrop SL, Bergstresser PR, Maino VC: Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 86:1408, 1995
17. Roederer M, Staal FTJ, Osada H, Herzenberg LA, Herzenberg LA: CD4 and CD8 T cells with high intracellular glutathione levels are selectively lost as the HIV infection progresses. Int Immunol 3:933, 1991
18. Safarin TA, Bredesen DE: Is apoptosis mediated by reactive oxygen species? Free Rad Res 21:1, 1994
19. Centers for Disease Control and Prevention: 1993 revised classification for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 41:1, 1992
20. Funderud S, Nustad K, Lea T, Vartdal F, Gaudernack G, Stenstad P, Ugelstad J: Fractionation of lymphocytes by immunomagnetic beads, in Klaus GGB (ed): Lymphocytes: A Practical Approach. Oxford, UK, Oxford, 1987, p 55
21. + lymphocytes in common variable immunodeficiency are associated with activation of the tumor necrosis factor system: Possible immunopathogenic role of oxidative stress. Blood 86:1383, 1995
22. Mason DY: Immunohistochemical labeling of monoclonal antibodies by APAAP immunoalkaline phophatase tecnique, in Bullock GR, Petrusz P (eds): Immunohisochemistry. vol 3. London, UK, Academic, 1985, p 25
23. Mansoor MA, Svardal AM, Ueland PM: Determination of in vivo redox status of cysteine, cysteinylglycine, homocysteine and glutathione in plasma. Anal Biochem 200:218, 1992
24. Svardal AM, Mansoor MA, Ueland PM: Determination of reduced, oxidized and protein-bound glutathione in human plasma with precolumn derivatization with monobromobimane and liquid chromotography. Anal Biochem 184:338, 1990
25. Meister A, Anderson ME: Glutathione. Annu Rev Biochem 52:711, 1983
26. Picker LJ, Teer JR, Feruson DB, Collins PA, Buck D, Terstappen LW: Control of lymphocyte circulation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selectin on T cells during the virgin to memory cell transition. J Immunol 150:1105, 1993
27. Ashman LK, Aylett GW: Expression of CD31 epitopes on human lymphocytes: CD31 monoclonal antibodies differentiate between naive (CD45RA+) and memory (CD45RO+) CD4 positive T cells. Tissue Antigens 38:208, 1991
28. Tough DF, Sprent D: Turnover of naive- and memory-phenotype T cells. J Exp Med 179:1127, 1994
29. Clement LT: Isoforms of the CD45 common leukocyte antigen family: Markers for human T-cell differentiation. J Clin Immunol 12:1, 1992
30. Rabin RL, Roederer M, Maldonado Y, Petru A, Herzenberg LA, Herzenberg LA: Altered representation of naive and memory CDS T cell subsets in HIV-infected children. J Clin Invest 95:2054, 1995
31. Bruunsgaard H, Pedersen C, Scheibel E, Pedersen BK: Increase in percentage of CD45RO+CD8+ cells is associated with previous severe primary HIV infection. J AIDS 10:107, 1995
32. Giorgi JV, Detels R: T-cell subset alterations in HIV-infected homosexual men: NIAID multicenter AIDS cohort study. Clin Immunol Immunopathol 52:10, 1989
33. van Noesel CJM, Gruters RA, Terpstra FG, Schellekens PTA, van Lier RAW, Miedema F: Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men. J Clin Invest 86:293, 1990
34. Gupta S: Subpopulations of CD4+ (T4+) cells in homosexual/bisexual men with persistent generalized lymphadenopathy. Clin Exp Immunol 68:1, 1987
35. Fletcher MA, Azen SP, Adelsberg B, Gjerset G, Hassett J, Kaplan J, Niland JC, Odom-Maryon T, Parker JW, Sites DP, Mosley JW, Transfusion Safety Study Group: Immunophenotyping in a multicenter study: The transfusion safety study experience. Clin Immunol Immunopathol 52:38, 1989
36. Vuillier F, Lapresle C, Dighiero G: Comparative analysis of CD4-4B4 and CD4-2H4 lymphocyte subpopulations in HIV negative homosexual, HIV seropositive and healthy subjects. Clin Exp Immunol 71:8, 1988
37. de Martini RM, Turner RR, Formenti SC, Boone DC, Bishop PC, Levine AM, Parker JW: Peripheral blood mononuclear cell abnormalities and their relationship to clinical course in homosexual men with HIV infection. Clin Immunol Immunopathol 46:258, 1988
38. Fauci AS: Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262:1011, 1993
39. Conlon K, Lloyd A, Chattopadhyay U, Lukacs N, Kunkel S, Schall T, Taub D, Morimoto C, Osborne J, Oppenheim J, Young H, Kelvin D, Ortaldo J: CD8+ and CD45RA+ human peripheral blood lymphocytes are potent sources of macrophage inflammatory protein 1α, interleukin-8 and RANTES. Eur J Immunol 25:751, 1995
40. Coochi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P: Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 270:1811, 1995
41. Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM, Horowitz ME, Magrath IT, Shad AT, Steinberg SM, Wexler LH, Gress RE: Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 332:143, 1995
42. Mayer M, Noble M: N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival. Proc Natl Acad Sci USA 91:7496, 1994
43. Hockenbery DM, Oltvai ZN, Yin X-M, Milliman CL, Korsmeyer SJ: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241, 1993
44. Katsikis PD, Wunderlich ES, Smith CA, Herzenberg LA, Herzenberg LA: Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus infected individuals. J Exp Med 181:2029, 1995
45. Hug H, Enari M, Nagata S: No requirement of reactive oxygen intermediates in Fas-mediated apoptosis. FEBS Lett 351:311, 1994
46. Farrant J, Spickett G, Matamoros N, Copas D, Hernandez M, North M, Chapel H, Webster ADB: Study of B and T cell phenotypes in blood from patients with common variable immunodeficiency. Immunodeficiency 5:159, 1994
47. Jaffe JS, Strober W, Sneller MC: Functional abnormalities of CD8+ T cells defined a unique subset of patients with common variable immunodeficiency. Blood 82:192, 1993
48. Aukrust P, Müller F, Frøland SS: Elevated serum levels of interleukin-4 and interleukin-6 in patients with common variable immunodeficiency are associated with chronic immune activation and low numbers of CD4+ lymphocytes. Clin Immunol Immunopathol 70:217, 1994
49. Aukrust P, Lien E, Kristoffersen AK, Müller F, Haug CJ, Espevik T. Frøland SS: Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency - possible immunologic and clinical consequences. Blood 87:674, 1996